Last reviewed · How we verify

The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients

NCT05611684 PHASE4 UNKNOWN

The effect of polyethylene glycol Losenatide on body fat, insulin resistance, weight, blood sugar, blood lipid, stomach volume and other factors in patients with type 2 diabetes through 12 week follow-up, and explore the factors affecting the efficacy, so as to provide more evidence-based medical basis for drug treatment and benefit patients.

Details

Lead sponsorNanjing First Hospital, Nanjing Medical University
PhasePHASE4
StatusUNKNOWN
Enrolment480
Start dateWed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionWed Dec 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

China